Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. filed an 8-K on August 15, 2024, under the legacy SPAC ticker SRNG. The company entered public markets through a merger with Soaring Eagle Acquisition Corp., a blank-check vehicle that completed its IPO in 2021 and was sponsored by Eagle Equity Partners. Soaring Eagle targeted technology and life sciences companies, ultimately combining with Ginkgo Bioworks, a synthetic biology firm that provides cell programming and biological platform services to industrial and pharmaceutical clients. The combined company subsequently began trading on the NYSE under the ticker DNA. Sign up on SpacDesk for complete filing data and deal analytics on this transaction.